These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 38326002

  • 1. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation.
    Kim IC, Kim SH, Youn JC, Kim D, Lee S, Kim H, Kim JJ, Jung MH, Rossano JW, Cherikh WS, Kobashigawa JA, Stehlik J.
    JACC Heart Fail; 2024 Feb; 12(2):395-405. PubMed ID: 38326002
    [Abstract] [Full Text] [Related]

  • 2. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 3. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
    Manlhiot C, Pollock-Barziv SM, Holmes C, Weitzman S, Allen U, Clarizia NA, Ngan BY, McCrindle BW, Dipchand AI.
    J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
    [Abstract] [Full Text] [Related]

  • 4. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
    Offor UT, Bacon CM, Roberts J, Powell J, Brodlie M, Wood K, Windebank KP, Flett J, Hewitt T, Rand V, Hasan A, Parry G, Gennery AR, Reinhardt Z, Bomken S.
    J Heart Lung Transplant; 2021 Jan; 40(1):24-32. PubMed ID: 33339556
    [Abstract] [Full Text] [Related]

  • 5. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 6. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
    Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, Hastie T, Oyer PE, Schroeder J.
    J Heart Lung Transplant; 2003 May; 22(5):505-14. PubMed ID: 12742411
    [Abstract] [Full Text] [Related]

  • 7. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry.
    Zaffiri L, Long A, Neely ML, Cherikh WS, Chambers DC, Snyder LD.
    J Heart Lung Transplant; 2020 Oct; 39(10):1089-1099. PubMed ID: 32654913
    [Abstract] [Full Text] [Related]

  • 8. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
    Lowery EM, Adams W, Grim SA, Clark NM, Edwards L, Layden JE.
    J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
    [Abstract] [Full Text] [Related]

  • 9. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
    Afify ZAM, Taj MM, Orjuela-Grimm M, Srivatsa K, Miller TP, Edington HJ, Dalal M, Robles J, Ford JB, Ehrhardt MJ, Ureda TJ, Rubinstein JD, McCormack S, Rivers JM, Chisholm KM, Kavanaugh MK, Bukowinski AJ, Friehling ED, Ford MC, Reddy SN, Marks LJ, Smith CM, Mason CC.
    Cancer; 2023 Mar 01; 129(5):780-789. PubMed ID: 36571557
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr Virus Predicts Malignancy After Pediatric Heart Transplant, Induction Therapy and Tacrolimus Don't.
    Giuliano K, Canner JK, Scully BB, Clarke N, Fraser CD, Ravekes W, Mettler B, Jacobs ML, Sen DG.
    Ann Thorac Surg; 2022 Nov 01; 114(5):1794-1802. PubMed ID: 34563503
    [Abstract] [Full Text] [Related]

  • 11. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.
    Chinnock R, Webber SA, Dipchand AI, Brown RN, George JF, Pediatric Heart Transplant Study.
    Am J Transplant; 2012 Nov 01; 12(11):3061-8. PubMed ID: 23072522
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 01; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 13. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 01; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.
    J Heart Lung Transplant; 2015 Nov 01; 34(11):1406-14. PubMed ID: 26279197
    [Abstract] [Full Text] [Related]

  • 15. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation.
    Hayes D, Breuer CK, Horwitz EM, Yates AR, Tobias JD, Shinoka T.
    Pediatr Cardiol; 2015 Dec 01; 36(8):1748-53. PubMed ID: 26187515
    [Abstract] [Full Text] [Related]

  • 16. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 17. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
    Huang JG, Tan MYQ, Quak SH, Aw MM.
    Transpl Infect Dis; 2018 Feb 15; 20(1):. PubMed ID: 29071779
    [Abstract] [Full Text] [Related]

  • 18. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.
    Boyle GJ, Michaels MG, Webber SA, Knisely AS, Kurland G, Cipriani LA, Griffith BP, Fricker FJ.
    J Pediatr; 1997 Aug 15; 131(2):309-13. PubMed ID: 9290623
    [Abstract] [Full Text] [Related]

  • 19. Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis.
    West SC, Friedland-Little JM, Schowengerdt KO, Naftel DC, Pruitt Freeze E, Smith KS, Urschel S, Michaels MG, Kirklin JK, Feingold B.
    Clin Transplant; 2019 May 15; 33(5):e13521. PubMed ID: 30861200
    [Abstract] [Full Text] [Related]

  • 20. Posttransplant lymphoproliferative disease and survival in adult heart transplant recipients.
    Hayes D, Tumin D, Foraker RE, Tobias JD.
    J Cardiol; 2017 Jan 15; 69(1):144-148. PubMed ID: 26972343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.